Last reviewed: May 31, 2026

Last updated: May 31, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

GLP-1 (glucagon-like peptide-1) is a hormone your intestines naturally produce in response to nutrient intake, particularly glucose and amino acids. Research shows that GLP-1 levels vary significantly between individuals due to genetic differences, with some people naturally producing higher baseline amounts than others.

For many patients, understanding personal GLP-1 production capacity—including genetic factors—can inform whether lifestyle modifications alone support metabolic goals or whether additional support may be beneficial. PlexusDx focuses on precision-wellness assessment to help you and your provider make informed decisions about your unique health pathway.

The Genetics Behind Your Natural GLP-1 Capacity

Your GLP-1 production is partly determined by variants in the GLP1R gene and related peptide pathway genes. Specific genetic variants influence how efficiently your intestinal cells produce GLP-1 and how your body responds to the hormone once released.

Twin and family studies suggest 40-60% of GLP-1 secretion variability is heritable. This means two individuals following identical diets and exercise routines may have significantly different baseline GLP-1 levels—an important consideration when evaluating whether natural strategies alone meet your metabolic needs.

Key Biomarkers and Genetic Variants That Influence GLP-1 Production

Several biomarkers and genetic factors shape your natural GLP-1 capacity and metabolic response. Understanding where you fall on this spectrum can guide whether lifestyle-first approaches or additional support may be most effective for your individual situation.

Biomarker/Genetic Factor What It Indicates for GLP-1 Production
GLP1R rs6923761 variant Influences GLP-1 receptor sensitivity and cellular response to the hormone
GIPR rs1800437 variant Affects glucose-dependent insulinotropic peptide (GIP) pathway, which works alongside GLP-1
Fasting glucose and insulin levels Reflect baseline metabolic function and can indicate GLP-1 secretion adequacy
FTO rs9939609 variant Associated with appetite regulation and metabolic risk; may correlate with GLP-1 production patterns

Lifestyle Strategies to Support Natural GLP-1 Production

High-protein meals, soluble fiber, and resistant starch stimulate intestinal L-cells to release more GLP-1. Studies show that whole grains, legumes, vegetables, and lean proteins—especially when eaten in balanced proportions—provide the nutrient signals your body needs for robust GLP-1 secretion.

Regular aerobic exercise and strength training enhance GLP-1 signaling and insulin sensitivity, amplifying the hormone's metabolic benefits. Even moderate-intensity activity (150 minutes weekly) measurably improves GLP-1-mediated glucose control and satiety signaling in most individuals.

When Lifestyle Alone May Not Be Sufficient: Provider Guidance and Personalization

For some individuals—particularly those with genetic variants associated with lower GLP-1 production or reduced receptor sensitivity—lifestyle modifications alone may not fully address metabolic goals. A qualified healthcare provider can assess your biomarkers, genetic context, and clinical response to determine whether additional support is warranted.

This is where precision assessment becomes valuable. Your provider may recommend biomarker testing, genetic insights, or a structured trial of evidence-based lifestyle changes before considering whether compounded GLP-1 medications or other pharmacological options align with your specific needs and health trajectory.

How PlexusDx Supports a More Personalized Approach

PlexusDx's Precision Peptide Genetic Test can help provide context about your genetic predispositions in the GLP1R, GIPR, FTO, and MC4R pathways—all genes relevant to GLP-1 production and metabolic response. These insights may help support a more informed conversation with your provider about whether natural strategies match your individual biology.

The genetic test reveals predispositions in peptide-signaling pathways, not exact GLP-1 medication response or production amounts. It should be interpreted with a qualified healthcare provider as part of a comprehensive assessment that includes clinical biomarkers, symptoms, and metabolic history.

Understanding your genetic context can empower you and your provider to make personalized decisions: whether to emphasize lifestyle optimization first, monitor progress over a defined period, or explore whether compounded GLP-1 medications might support your goals more effectively given your individual genetic and metabolic profile.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month, or $298 standalone) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection starts at $229-$309/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Related Reading

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake

~60 seconds · $0 charged until your provider approves